Comprehensive SNP Genotyping And Analysis Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

SNP Genotyping And Analysis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market sector for SNP genotyping and analysis has experienced rapid expansion in recent years, accelerating from $15.45 billion in 2024 to an estimated $18.5 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 19.7%. This historical growth can be linked to multiple factors, such as increased funding for biomedical research, the proliferation of personalized medicine initiatives, a robust expansion in agricultural genomics, the high prevalence of chronic diseases, and the emergence of commercial genomic services.

SNP Genotyping And Analysis Market Size Forecast: What's the Projected Valuation by 2029?
The SNP genotyping and analysis market is anticipated to experience significant expansion in the coming years, and predictions suggest that it will reach a value of "$38.58 billion by 2029 with an impressive compound annual growth rate (CAGR) of 20.2%. This projected upsurge over the forecast period can be associated with multiple factors including the scale-up of population genomics projects, increased attention to the diagnosis of rare diseases, the increasing role of companion diagnostics and precision oncology, growing consumer interest in genomics (DTC), and legal backing for genomic medicine. The period in question is also expected to witness key trends such as advancements in genotyping technology platforms, the integration of artificial intelligence and bioinformatics, an expansion of research in oncology, increased usage in forensic and lineage testing, and the advancement of portable genotyping devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/snp-genotyping-and-analysis-global-market-report

What Are the Drivers Transforming the SNP Genotyping And Analysis Market?
The SNP genotyping and analysis market is anticipated to grow due to the increasing prevalence of genetic disorders. These conditions are caused by abnormalities in a person's DNA, which may be passed down from one or both parents or occur due to mutations during cell division. Rising awareness and enhanced diagnostic technologies have exacerbated the issue of genetic diseases, leading to more diagnoses and greater recognition of these disorders. SNP genotyping and analysis can aid in mitigating genetic diseases by pinpointing genetic variations linked to disease risk, progression, and reaction to medication, thus facilitating early detection and individualized treatment. For example, a report published by Cystic Fibrosis Australia in February 2024 revealed that by 2022, the number of people living with cystic fibrosis in Australia had increased to 3,738, an increase from 3,616 cases in 2021. Consequently, the escalating prevalence of genetic disorders is fuelling the expansion of the SNP genotyping and analysis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24402&type=smp

Which Emerging Trends Are Transforming the SNP Genotyping And Analysis Market in 2025?
The primary players in the SNP genotyping and analysis market are directing their efforts towards the creation of technologically superior solutions; an example being large-scale low-pass whole genome sequencing for agriculture to handle primary issues in genotyping for molecular breeding of agricultural diploid species. The technique of agricultural whole genome sequencing involves interpreting the full genetic content of farm produce or livestock to boost characteristics like production, immunity to diseases, and adaptability to the environment. For instance, MGI Tech, a biotechnology firm based in China, introduced an extremely effective comprehensive workflow solution for agricultural large-scale low-pass whole genome sequencing (low-pass WGS) in June 2024. This solution encompasses an automated complete-process product collection that ranges from DNA extraction to sequencing, and SNP & InDel calling, all the while tailoring specifically for the genotyping of molecular breeding agricultural diploid species. It boasts of state-of-the-art automation platforms and uses MGI's DNBSEQ-T7 and DNBSEQ-G400 sequencers to deliver extreme throughput and flexibility. The workflow also provides pig reference panels and data analysis software to simplify genotyping without the need for creating a custom database.

Which Segments in the SNP Genotyping And Analysis Market Offer the Most Profit Potential?
The snp genotyping and analysis market covered in this report is segmented -

1) By Sample Type: Genomic DNA, Ribonucleic Acid (RNA), Cell-Free DNA (cfDNA), Plasma Samples, Whole Blood
2) By Technology: Microarrays And GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, Other Technologies
3) By Application: Disease Diagnostics, Pharmacogenomics, Precision Medicine, Forensic Science, Agriculture And Livestock
4) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical And Biotechnological Companies, Diagnostic Laboratories, Academic And Government Institutions

Subsegments:
1) By Genomic DNA: Whole Genome Sequencing (WGS), Targeted Sequencing, Microarrays
2) By Ribonucleic Acid (RNA): RNA-Seq, Expression Profiling, Microarrays
3) By Cell-Free DNA (cfDNA): Liquid Biopsy, Non-Invasive Prenatal Testing (NIPT), Oncology Research
4) By Plasma Samples: Circulating Tumor DNA (ctDNA), Liquid Biopsy Applications, Diagnostics
5) By Whole Blood: DNA Extraction And Analysis, Blood-Based Genomic Studies, Genotyping And Molecular Diagnostics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24402&type=smp

Which Firms Dominate the SNP Genotyping And Analysis Market by Market Share and Revenue in 2025?
Major companies operating in the SNP genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International

Which Regions Offer the Highest Growth Potential in the SNP Genotyping And Analysis Market?
North America was the largest region in the SNP genotyping and analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the SNP genotyping and analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24402

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.